Pharma News, 2018

Hikma Pharmaceuticals has established itself as a top sterile injectables manufacturer in the U.

AstraZeneca’s product sales returned to growth in the third quarter, with new medicines and emerging markets driving performance.

UK-based Mallinckrodt has revealed that its experimental therapy for Niemann-Pick Type C failed to hit targets in a recently completed registration trial.

While Mylan’s third quarter results impressed analysts, the generics drugmaker is still dealing with some significant manufacturing issues, some of them not of its own making.

Regeneron’s Eylea has for the first time generated over $1 billion in quarterly U.

With generics expected sooner than later for eye drug Restasis, Allergan has canceled a $200 million expansion at its manufacturing plant in Waco, Texas, and instead spent most of it on other manufact...

Women whose body clocks mean they are "morning people" have a lower risk of developing breast cancer, say UK researchers.

People with type 1 diabetes may be more likely to develop potentially fatal complications when they use cannabis, a recent study suggests.

(Reuters) - Pfizer Inc said on Friday the U.

Nov.

FOSTER CITY, Calif.

Earnings reports haven’t been kind to shares of Teva Pharmaceutical Industries lately.